Saturday, November 8, 2025

TOPICS

Home Tags Epivax

Tag: Epivax

EPIVAX HAS WON a $324,000 grant to develop a web tool that will quickly determine whether Pompe disease patients are at risk for an immune response to enzyme replacement therapy.

EpiVax wins $324K NIH grant to improve Pompe disease treatment

PROVIDENCE — EpiVax Inc. has received a $324,980 Small Business Innovation Research grant to continue development of a web-based test for people at risk...
SELLING R.I.: Jesse Saglio, right, the new president and chief operating officer of R.I. Commerce Corp. at a recent public meeting of the agency’s board. He says Commerce will step up its focus on helping local and small businesses this year. / PBN PHOTO/MICHAEL SALERNO

New Commerce RI President Jesse Saglio promises ‘more of the same’...

Since October 2015, Jesse Saglio, 46, has been a key behind-the-scenes player at R.I. Commerce Corp., most recently serving as managing director and head...
EPIVAX PRESIDENT AND CEO Dr. Anne S. De Groot. EpiVax has launched a venture-backed spinoff, Epivax Oncology. / PBN FILE PHOTO

EpiVax launches EpiVax Oncology for personalized cancer vaccines

PROVIDENCE — Immunolgy engineering biotech firm EpiVax Inc. has launched EpiVax Oncology Inc., a venture-backed spinoff focused on the development of personalized therapeutic cancer...
FAST SEQUENCING: Dr. Anne S. De Groot, EpiVax Inc. CEO and chief strategy officer, says the Providence company has spent the past 20 years developing immunoinformatics tools. EpiVax spinoff EpiVax Oncology will use those tools along with fast sequencing to design cancer vaccines specific to individual patients. / PBN PHOTO/MICHAEL SALERNO

Renowned vaccine researcher Dr. Anne S. De Groot is ready to...

In 1997, Dr. Anne S. De Groot founded EpiVax Inc. in ­Providence, backed by a Small Business Innovation Research grant from the National Institutes...

Public investment in basic research yields major victories

Dr. Anne S. De Groot is a major success story, not just in Rhode Island but across the globe. She bridges the research and clinical...
FULLY ENGAGED: EpiVax staff know that what they are working on has a real impact on health, and with a highly collaborative workplace, they all are an important part of the work. / COURTESY EPIVAX

Small companies, 18, EpiVax Inc.

Employees in R.I.: 24 Founder, CEO and Chief Science Officer Dr. Anne S. De Groot Questions answered by: Stephanie Vece, human resources manager What three words best...
- Featured Event -

Latest News